NCT06388642

Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients

← Hub

Registry fields

Overall status: COMPLETED
Conditions: Erythropoietic Protoporphyria
Study type: INTERVENTIONAL
Phase: PHASE1, PHASE2
Primary purpose: OTHER
Intervention type: DRUG
Interventions: Afamelanotide 16mg implant
Lead sponsor: Clinuvel Europe Limited (INDUSTRY)

Cached at: 2026-07-28 02:39:08

View on ClinicalTrials.gov

Brief summary

The purpose of this study is to evaluate the concentration of afamelanotide in serum after the administration of afamelanotide in adolescent and adult EPP patients.

Contact

Need a report or Korean medical writing based on this trial?

Request a report Medical writing Custom research report